Zobrazeno 1 - 5
of 5
pro vyhledávání: '"K R, Oettel"'
Autor:
K R, Oettel, O H, Wesly, M R, Albertini, J A, Hank, O, Iliopolis, J A, Sosman, K, Voelkerding, S Q, Wu, S S, Clark, P M, Sondel
Publikováno v:
Blood. 83:3390-3402
Immunocompetent cells in bone marrow allografts have been associated with a graft-versus-leukemia (GVL) effect. To further characterize effector mechanisms that may be involved in this GVL phenomenon, we have previously established an in vitro model
Autor:
J. E. Schroeder, Ronald S. Go, K. R. Oettel, N. R. Ruther, J. K. Keller, Michelle A. Mathiason
Publikováno v:
Journal of Clinical Oncology. 28:6084-6084
6084 Background: We performed this study in order to describe the nature of current cancer trials in the US. Methods: From the National Cancer Institute website, we obtained a list of 2,262 therape...
Publikováno v:
Journal of Clinical Oncology. 26:17550-17550
17550 Background: The vast majority of patients with lung cancer are treated in a community setting. Patients with Non Small Cell Lung Cancer (NSCLCA) can have a poor prognosis with variability in ...
Autor:
M R, Albertini, K R, Oettel, G, Weil-Hillman, M J, Lindstrom, K, Schell, J A, Hank, P M, Sondel
Publikováno v:
Journal of biological response modifiers. 9(5)
Eleven patients receiving weekly cycles of therapy with recombinant interleukin-2 (IL-2) were evaluated with a sensitive limiting dilution analysis to determine lymphokine-activated killer (LAK) cell precursor frequencies in peripheral blood lymphocy
Autor:
Jennifer A. Lee, K. R. Oettel, L. Meyer, Ben George, R. Joseph, Michelle A. Mathiason, Ronald S. Go
Publikováno v:
Journal of Clinical Oncology. 25:17064-17064
17064 Background: The National Comprehensive Cancer Network (NCCN) provides yearly updated guidelines for the management of patients diagnosed with small cell lung cancer (SCLC). Compliance to clinical guidelines may improve patient care and outcome,